Talis Biomedical Corporation Overview
Pro stress-test →Talis Biomedical is a molecular diagnostics company that previously developed point-of-care testing systems for infectious diseases. The company is currently evaluating strategic alternatives including acquisition, merger, or restructuring as it has minimal active operations.
Strategic Profile
Pro stress-test →Once positioned as an innovator in molecular testing with its Talis One® System for rapid infectious disease diagnostics, the company now focuses on financial restructuring and strategic repositioning. The company maintains liquidity through cash reserves but faces operational challenges reflected in its penny-stock status and delisting risks.
Competitive Landscape
Pro stress-test →Talis competes in the molecular diagnostics space with established players like Abbott Diagnostics and Quidel. However, with minimal operations, it is no longer an active competitor. The market leader position has shifted to larger, better-funded diagnostic companies.
Industry Context
Talis Biomedical Corporation operates in Medical Devices / Molecular Diagnostics.
Key facts
Founded: 2013 · Headquarters: Chicago, Illinois · Revenue: $0 · Market cap: $15.9M